共 208 条
[1]
Fiore AE(2011)Uyeki TM; Centers for Disease Control and Prevention (CDC): antiviral agents for the treatment and chemoprophylaxis of influenza –- recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep 60 1-24
[2]
Fry A(2009)Neuraminidase inhibitors–the story behind the Cochrane review BMJ 339 b5164-51
[3]
Shay D(2012)Patterns in influenza antiviral medication use before and during the 2009 H1N1 pandemic, vaccine safety data link project, 2000–2010 Influenza Other Respi Viruses 6 e143-1719
[4]
Gubareva L(2012)Nationwide surveillance of influenza during the pandemic (2009–10) and post-pandemic (2010–11) periods in Taiwan PLoS One 7 e36120-311
[5]
Bresee JS(2010)Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection N Engl J Med 362 1708-262
[6]
Doshi P(2012)US antiviral resistance surveillance working group: oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010–11 Emerg Infect Dis 18 308-1856
[7]
Greene SK(2010)Early findings of oseltamivir-resistant pandemic (H1N1) 2009 influenza A viruses in Taiwan Antiviral Res 88 256-34
[8]
Shay DK(2011)Continued emergence and changing epidemiology of oseltamivir-resistant influenza A(H1N1)2009 virus, United Kingdom, winter 2010/11 Euro Surveill 16 19784-545
[9]
Yin R(2011)Seroprevalence and severity of 2009 pandemic influenza A H1N1 in Taiwan PLoS One 6 e24440-146
[10]
McCarthy NL(2011)Age distribution of cases of 2009 (H1N1) pandemic influenza in comparison with seasonal influenza PLoS ONE 6 e21690-479